Life Sciences and Healthcare - France | Fieldfisher
Skip to main content

Life Sciences and Healthcare

Our Life Sciences and Healthcare lawyers handle the full spectrum of regulatory issues arising in the pharmaceutical and biotech sectors.

Recent Deals

  • We assisted the US Company Teladoc with the acquisition of M├ędecin Direct, a French company in the telemedicine sector. 

  • We assisted with the acquisition of UPSA, a subsidiary of BMS. 

Cell and gene therapy

Cell and gene therapy (CGT) also known as advanced therapy medicinal products (ATMPs) is predicted to be the future of medicine.

CGT has the power to change the way we treat various chronic and life shortening illnesses that had previously been seen as incurable. With the paradigm potentially shifting from one of illness management to cure, CGT has the attention of the media, investors, regulators, pharmaceutical companies and the wider life sciences industry.

Find out more